AP2395A
New composition containing quinoline compounds.
Abstract
The invention relates to a stable solid pharmaceutical composition, wherein the solid pharmaceutical composition basically and is maintained the effective quantity's type (II) a pH wire is higher than 8 nicotine reaction members or with divalent metal positive ion salt and at least one agent excipient composed of; The type II (a) during room temperature storage is at least 3 years basically stable. The invention further relates of stabilized (II) salt the method. The invention further relates type (II) crystallization salt and preparation of the salty the method.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US4547511A | Cites | United States of America | Search report |
| US5716638A | Cites | United States of America | Search report |
46 members in 24 offices
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 0400235 | Sweden | A | |
| 0400235 | Sweden | A | |
| 2005050485 | European Patent Office (EPO) | W | |
| 2005050485 | European Patent Office (EPO) | W | |
| SE20040000235 | – | – | – |
| WO2005EP50485 | – | – | – |
Members46
| Document | Office | Kind | |
|---|---|---|---|
| AU2005210174A1 | Australia | A1 | |
| CA2552463A1 | Canada | A1 | |
| WO2005074899A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2005192315A1 | United States of America | A1 | |
| AP2006003674A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| NO20063931L | Norway | L | |
| IL176255A0 | Israel | A0 | |
| EP1720531A2 | European Patent Office (EPO) | A2 | |
| KR20060130191A | Republic of Korea | A | |
| WO2005074899A3 | World Intellectual Property Organization (WIPO) | A3 | |
| BRPI0506906A | Brazil | A | |
| CN1980669A | China | A | |
| JP2007520529A | Japan | A | |
| ZA200605619B | South Africa | B | |
| HK1105866A | Hong Kong, China | A | |
| HK1105866A1 | Hong Kong, China | A1 | |
| RU2006132070A | Russian Federation | A | |
| RU2339622C2 | Russian Federation | C2 | |
| US7589208B2 | United States of America | B2 | |
| US2009232889A1 | United States of America | A1 | |
| UA90463C2 | Ukraine | C2 | |
| NZ548469A | New Zealand | A | |
| AU2005210174B2 | Australia | B2 | |
| EP1720531B1 | European Patent Office (EPO) | B1 | |
| AT505186T | Austria | T | |
| ATE505186T1 | Austria | T1 | |
| DE602005027445D1 | Germany | D1 | |
| PT1720531E | Portugal | E | |
| DK1720531T3 | Denmark | T3 | |
| SI1720531T1 | Slovenia | T1 | |
| ES2364754T3 | Spain | T3 | |
| PL1720531T3 | Poland | T3 | |
| CN1980669B | China | B | |
| IL176255A | Israel | A | |
| JP4864724B2 | Japan | B2 | |
| AP2395AThis record | African Regional Intellectual Property Organization (ARIPO) | A | |
| KR20120062029A | Republic of Korea | A | |
| KR101189557B1 | Republic of Korea | B1 | |
| US8314124B2 | United States of America | B2 | |
| KR20130012084A | Republic of Korea | A | |
| CA2552463C | Canada | C | |
| US2013123301A1 | United States of America | A1 | |
| US8754104B2 | United States of America | B2 | |
| KR101457463B1 | Republic of Korea | B1 | |
| NO337235B1 | Norway | B1 | |
| BRPI0506906B1 | Brazil | B1 |
Numbers
- Publication, DOCDB
- 2395
- Publication, EPODOC
- AP2395
- Application
- 20060003674
- Application, DOCDB
- 2006003674
- Application, EPODOC
- AP20060003674
Titles
- English
- New composition containing quinoline compounds.
Classification
- CPC, 13
- A61K31/47
- A61K31/4704
- A61K31/4709
- A61K9/1617
- A61K9/2009
- A61K9/2013
- A61K9/2054
- A61K9/2059
- A61K31/4706
- A61P29/00
- A61P37/00
- A61P43/00
- C07D215/22
- IPC, 5
- A61K9 00
- A61K9 16
- A61K9 20
- A61K31 47
- A61K31 4706